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ABSTRACT
Tumor hypoxia promotes neoangiogenesis and contributes to the radio- and 
chemotherapy resistant and aggressive phenotype of cancer cells. However, the 
migratory response of tumor cells and the role of small GTPases regulating the 
organization of cytoskeleton under hypoxic conditions have yet to be established. 
Accordingly, we measured the proliferation, migration, RhoA activation, the mRNA and 
protein levels of hypoxia inducible factor-1alpha (HIF-1α) and three small G-proteins, 
Rac1, cdc42 and RhoA in a panel of five human tumor cell lines under normoxic and 
hypoxic conditions. Importantly, HT168-M1 human melanoma cells with high baseline 
migration capacity showed increased HIF-1α and small GTPases expression, RhoA 
activation and migration under hypoxia. These activities were blocked by anti- HIF-1α 
shRNA. Moreover, the in vivo metastatic potential was promoted by hypoxia mimicking 
CoCl2 treatment and reduced upon inhibition of HIF-1α in a spleen to liver colonization 
experiment. In contrast, HT29 human colon cancer cells with low migration capacity 
showed limited response to in vitro hypoxia. The expression of the small G-proteins 
decreased both at mRNA and protein levels and the RhoA activation was reduced. 
Nevertheless, the number of lung or liver metastatic colonies disseminating from 
orthotopic HT29 grafts did not change upon CoCl2 or chetomin treatment. Our data 
demonstrates that the hypoxic environment induces cell-type dependent changes 
in the levels and activation of small GTPases and results in varying migratory and 
metastasis promoting responses in different human tumor cell lines.
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INTRODUCTION
Oxygen supply is essential for the growth of 
cells and is often reduced in solid tumors, particularly 
in the center of the tumor mass. Adaptation to the 
hypoxic condition supports tumor growth and survival. 
Furthermore, tumor hypoxia might be associated with 
resistance to radio- and chemotherapy [1-3]. HIF-1 
(hypoxia inducible factor-1), the major regulator of 
cellular response to tissue hypoxia, is a heterodimer 
protein consisting of HIF-1α and HIF-1β subunits [4]. 
Under normal oxygen tension HIF-1α binds to the von 
Hippel-Lindau protein and is degraded via the ubiquitin-
dependent pathway [5]. During this process, specific 
proline residues undergo posttranslational hydroxylation 
by prolyl hydroxylases [6]. Under hypoxia, HIF-1α 
heterodimerizes with the constitutively produced HIF-
1β subunit within the nucleus and binds to the hypoxia 
responsive element (HRE). In this way HIF-1 activates 
different genes involved in angiogenesis, migration and 
survival [7], such as erythropoietin or VEGFs [8]. The 
same genes are often found to be overexpressed in tumor 
cells, suggesting that these pathways are also involved in 
tumor progression [9].
The members of Rho family small G-proteins, 
Rac1, cdc42 and RhoA are approximately 21 kDa proteins 
that regulate a wide spectrum of cellular functions, such 
as cell growth, cytoskeletal reorganization, membrane 
trafficking and angiogenesis [10]. Their activity is 
regulated by guanine nucleotide exchange factors (GEFs), 
guanine nucleotide dissociation inhibitors (GDIs) and 
GTPase-activated proteins (GAPs) [11]. Increasing 
amount of evidence supports the role of Rho GTPases 
in tumorigenesis [12], metastasis formation [13], cell-
cycle control [14] and apoptosis [15]. HIF-1α has been 
described to influence cell motility via the regulation of 
the expression and activation of RhoA. In a mesenchymal 
stem cell migration model the amount of active RhoA 
was reduced at 1% oxygen level, whereas activation of 
RhoA under hypoxic conditions rescued migration [16]. 
In a recent publication, Gilkes et al described 3 direct 
HIF binding sites on RhoA and ROCK1 genes as well, 
indicating the HIF-mediated regulation of the expression 
of these proteins. In their breast cancer model, hypoxia 
enhanced cell migration through actin polymerization, 
myosin light chain kinase phosphorylation and activation 
of focal adhesion kinase [17].
Although hypoxic conditions have been shown to 
increase tumor cell motility [18, 19] and aggressiveness 
[20] through the activation of small GTPases, the cell-
type dependence of the expression and activation of 
RhoA, cdc42 or Rac1 is unknown. Therefore, the aim 
of this study was to investigate the effect of hypoxia on 
the expression of HIF-1α, RhoA, cdc42 and Rac1, RhoA 
activation, cell proliferation and migration using five 
tumor cell lines of different tissue origin. Additionally, the 
in vivo metastatic potential was measured in the different 
model system using CoCl
2
 treatment for the stabilization 
of HIF-1α.
RESULTS
Differential proliferative response to 
experimental hypoxia
Hypoxia had a cell-type dependent effect on tumor 
cell proliferation. However, the increased proliferation 
of HT1080 human fibrosarcoma cells at 5% O
2
 level was 
the only statistically significant alteration. In contrast, 1% 
O
2
 level modestly decreased the proliferation of HT1080 
cells. While the proliferation capacity of the HT168-M1 
melanoma and HT25 colon carcinoma cell lines modestly 
increased both at 1% and 5% O
2
 levels compared to 
normoxia, the proliferation of HT29 colon carcinoma cells 
decreased, especially at the 1% O
2
 level. No differences 
were detected between hypoxic and normoxic PE/CA PJ15 
head and neck carcinoma cells (Table 1).
Varying effect of hypoxia on tumor cell 
migration
Next, we characterized the effect of hypoxia 
on the motility of the cells. First we used time-lapse 
videomicroscopy to measure the baseline migration 
capacity of the five tumor cell lines. HT168-M1, HT1080 
and PE/CA PJ15 cells migrated at a relatively high speed, 
while the two colon carcinoma cell lines (HT25 and HT29) 
were moving very slowly (Figure 1A). To measure the 
effect of hypoxia on fibronectin-induced migration cells 
were analyzed in Boyden chamber assay. Tumor cells were 
allowed to migrate for 6 or 20 hours, following a 72-hour 
preincubation period at 1% and 5% O
2
 concentration or 
under normoxic conditions. Preincubation under hypoxic 
conditions resulted in increased migration of HT168-M1 
and HT1080 cells. In the case of PE/CA PJ15 cells only 
the 5% O
2
 level increased significantly the migration 
compared to normoxic condition (Figure 1B). The HT25 
and HT29 cell lines displayed no migration capacity in the 
Boyden chamber assay, even under normoxic conditions. 
Thus we further investigated the effect of hypoxia using 
time-lapse videomicroscopy. Cells were monitored under 
normoxic conditions for 24 h and then the oxygen tension 
was changed to 5% or 1% for 72 hours. Figure 1C-1D 
show the migration of the cells detected during the 72-96 
h period (third day in hypoxia) relative to that observed 
during the first 24 hours (normoxia). The results of 
the time-lapse videomicroscopy and Boyden chamber 
migration assay showed a good correlation. HT1080 and 
HT168-M1 cells showed increased migration under both 
hypoxic conditions, and HT168-M1 cells moved faster 
as oxygen tension decreased. PE/CA PJ15 cells showed 
increased motility at 5% O
2
 level, but there were no 
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significant changes under 1% O
2
 hypoxia compared to 
normoxic control. The motility of the two colon cancer 
cell lines (HT25 and HT29) was unchanged under hypoxia 
compared to normoxic condition.
Although, due to the technical setting of the 
experiment, the results of the time-lapse video microscopy 
exclude the possible effect of reoxygenization in the 
induction of cell movement under hypoxia, we repeated 
the Boyden chamber experiment without preincubation 
of the cells in hypoxic conditions. HT168-M1 tumor 
cells from normoxic conditions were allowed to migrate 
in hypoxic chamber for 6 hours and cell migration was 
Table 1: Effect of hypoxia on the proliferation of different tumor cells
5% O2 1% O2
HT168-M1 121±4.9 110±1.34
HT1080 154±16.9* 65±16.6
HT25 126±8.4 107±5.6
HT29 88±3.2 66±16.9
PE/CA PJ15 107±2.7 106±5.3
Data are means±SD in percentage of control (normoxic) values under different hypoxic conditions. Representative data are 
from at least 6 parallels from three independent investigations; *p<0.05.
Figure 1: Effect of hypoxia on tumor cell migration. (A) Baseline motility of the five tumor cell lines measured under normoxic 
conditions for 24 h using time-lapse videomicroscopy. Curves represent the mean ± SD of migrated distance during the test period. Note 
that the two colon carcinoma cell lines showed very low migration capacity. (B) Migration of three tumor cell lines in Boyden chamber 
using fibronectin as chemoattractant. Cells were preincubated under hypoxic conditions for 72 h prior to the 6 h (HT168-M1, HT1080) or 
20 h (PE/CA-PJ15) migration test at normoxia. Cell migration was quantified by counting the cells in the lower chambers covered with the 
chemoattractant fibronectin. Data are mean ± SD, n=6; *p<0.05. In the time-lapse videomicroscopic test the relative migration capacity of 
the cells was determined based on the analysis of snapshots of microscopic fields taken every 5 minutes for 1 day at normoxic conditions 
and for 3 days at 5% (C) or 1% (D) oxygen levels. The captured phase contrast pictures were analyzed using a cell-tracking program 
enabling manual marking of individual cells. Relative migration distance is represented by the ratio of the average displacement of the cells 
under hypoxia and normoxia (mean ± SD). 1= same migration capacity of the cells under hypoxic and normoxic condition.
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found increased in this experimental setup as well (number 
of migrating cells per field of view was 44 ± 8.9 cells in 
normoxia and 86 ± 6.4 cells in hypoxia).
Cell-type dependent changes in expression 
of HIF-1α and cytoskeleton regulating small 
G-proteins in hypoxia
To characterize the molecular background of the 
response to hypoxia, we examined the mRNA levels of 
HIF-1α, Rac1, cdc42 and RhoA in the different cell lines 
after 72h hypoxia treatment. In the case of HT168-M1 all 
of the examined markers were increased at both 5% and 
1% O
2
 level (Figure 2A). In HT1080 cells, HIF-1α mRNA 
expression increased 4-fold in 5% O
2
 environment and the 
other markers were also higher compared to the normoxic 
values (Figure 2B). However, mRNA levels remained 
normal or decreased at 1% O
2
.
Interestingly, HIF-1α mRNA expression in HT25 
cells decreased only at 5% O
2
 level (Figure 2C), while 
in HT29 (Figure 2D) and PE/CA PJ15 (Figure 2E) in 
both (5% and 1% O
2
) hypoxic conditions. HT29 cells 
demonstrated decreased expression of all examined small 
G-proteins RNA at both hypoxic oxygen levels.
Differential hypoxia induced RhoA activation in 
tumor cells
We used an ELISA-based method for the detection 
of active RhoA following a 72 h preincubation of the cells 
under hypoxic conditions. In HT168-M1 cells the level of 
active RhoA was increased under both hypoxic conditions. 
Similar results were found in the case of HT1080 cells 
at 5% O
2
 level. However, in HT29 cells the activation 
of RhoA significantly decreased at both reduced oxygen 
levels. In HT25 and PE/CA PJ15 cells no significant 
changes in RhoA activation were found. (Table 2).
The effect of hypoxia on protein expression of 
the three small GTPases and HIF-1α
For the further analysis of the effect of hypoxic 
environment on tumor cells we selected a cell line with 
high baseline migration capacity (HT168-M1) and one 
with low migration capacity (HT29). In these cells, 
protein expression level of RhoA, Rac1 and cdc42 was 
measured by Western blot analyses. Most of the results 
correlated with findings at the mRNA level: RhoA and 
Rac1 protein levels were increased in HT168-M1 cells, 
but all the three proteins were decreased in HT29 cells 
after 72 h incubation in hypoxia (1% O
2
 level, Figure 3A). 
Because we used CoCl
2
 for the stabilization of HIF-1α in 
our animal experiments, the HIF-1α protein levels were 
measured in CoCl
2
-treated cells as well to control HIF-
1α induction. HIF-1α protein level was increased after 
hypoxia induction by 6 and 24 h CoCl
2
 treatment in both 
cell lines (Figure 3B).
Experimental hypoxia changes metastatic 
potential in a cell-type dependent manner
In vivo hypoxia was generated by adding CoCl
2
 to 
the drinking water (260 mg/l during the whole period of 
the experiment). HIF-1α activity was blocked by chetomin 
treatment (1 mg/kg dissolved in DMSO i.p., twice a week 
for 4 weeks). The effect of hypoxia was evaluated in 
colonization and metastasis models.
In the xenograft model of highly migratory 
HT168-M1 cells the number of metastases was 
significantly higher in the CoCl
2
 group, and was lower 
in the chetomin-treated group compared to the untreated 
controls (Figure 3C). However, in the HT29 (cells with 
limited baseline migration activity) metastasis model there 
were no significant changes in the number of lung or liver 
metastases of the CoCl
2
-treated group compared to the 
controls (Figure 3D).
HIF-1α downregulation changes hypoxia-
induced small G-protein expression and RhoA 
activation
In order to demonstrate that HIF-1α mediates the 
hypoxia-induced changes in small G-protein expression, 
migration and metastasis formation, we decreased HIF-1α 
level by shRNA method in the two selected cell lines. The 
shRNA significantly decreased HIF-1α protein expression 
in both investigated cell lines under hypoxic (1% O
2
) 
condition (Figure 4A). The increased gene expression 
of HIF-1α and the three small G-proteins under hypoxic 
conditions (1% O
2
 level), described above, was blocked 
by shRNA treatment in HT168-M1 cells (Figure 4B). 
The shRNA treatment had no effect on the decreased 
gene expression in hypoxia in HT29 cells (Figure 4C). 
Moreover, HIF-1α silencing in HT168-M1 cells did not 
change RhoA activation in normoxia, but blocked the 
induction of RhoA activation under hypoxic (1% O
2
 level) 
conditions (Figure 4D). At the same time, in HIF-1α 
silenced HT29 cells RhoA activation was decreased under 
both normoxic and hypoxic conditions (Figure 4E).
HIF-1α downregulation changes cell migration 
and metastatic potential
HIF-1α silencing did not change the migratory 
activity of HT168-M1 cells under normoxia. However, the 
increased cell motility in hypoxia (1% O
2
, 72h incubation 
time) was completely blocked in the HIF-1α silenced cells 
(Figure 5A). We have found that HIF-1α downregulation 
had no effect on the migratory capacity of HT29 cells 
either in hypoxic or normoxic conditions (Figure 5B).
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Figure 2: mRNA expression of HIF-1α, RhoA, Rac1 and cdc42 under normoxic and hypoxic conditions. (A-E) Relative 
mRNA expression under hypoxic conditions (72h incubation) compared to normoxia (normoxic values=1). Data are mean ± SD, n=3, 
*p<0.05.
Table 2: RhoA activation in the different cell lines under hypoxic conditions
5% O2 1% O2
HT168-M1 150.5 ± 1.9 * 130.8 ± 1.0 *
HT1080 171.7 ± 10.2 * 100.3 ± 0.4
HT25 119.8 ± 21.2 95.1 ± 9.5
HT29 77.4 ± 4.3 * 75.8 ± 7.8 *
PE/CA PJ15 104.8 ± 1.6 112 ± 5.7
Data are means ± SD in percentage of control (normoxic) values under different hypoxic conditions; representative data of 
3 independent experiments. *p<0.05
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At the same time, the result of in vivo liver 
colonization assay using HT168-M1 cells showed that 
HIF-1α silencing decreased the CoCl
2
 administration-
induced increase in metastatic potential of HT168-M1 
(Figure 5C).
DISCUSSION
A growing body of evidence underlines the 
importance of decreased oxygen levels in tumor 
progression, as well as chemo- and radiotherapy 
resistance of solid tumors [21, 22]. In the present study we 
demonstrated that hypoxia (1% and 5% O
2
 levels) exerts 
cell-type dependent effects on in vitro cell proliferation in 
our panel of tumor cell lines. Our results are in line with 
several previous studies demonstrating that lower oxygen 
concentration may decrease [23-25] or has no effect on the 
proliferation of different tumor cells [26].
Migration, in part regulated by RhoA, Rac1 and 
cdc42 small G-proteins, has a pivotal role in tumor 
progression and metastasis formation. The hypothesis that 
hypoxia promotes tumor cell aggressiveness, including 
increased motility and invasion capacity of the cancer cells 
[27-29] is supported by a series of experimental findings 
[30-32]. On the other hand, several studies indicate that in 
certain tumor cell types hypoxia does not induce a change 
in migration capacity, suggesting that the inherent motility 
of tumor cells may influence the migratory response to 
hypoxia [26]. Therefore, we first determined the baseline 
migration capacity of all five cell lines. Using time-
lapse videomicroscopy under normoxia, the two colon 
carcinoma cell lines showed restricted migration capacity, 
while the other three cell types showed significant cell 
migration. We measured the change in motility under 
hypoxic conditions compared to the normoxic values 
and found that lower oxygen level increased the motility 
in most of the cell lines with higher baseline migration 
activity (HT168-M1, HT1080, PE/CA PJ15). However, 
in the two colon cancer cell lines hypoxia had no effect 
on cell migration. Moreover, we obtained similar results 
when we used Boyden chamber migration assay under 
normoxia following a 72 h hypoxic preincubation period: 
the migration capacity of HT168-M1, HT1080 and PE/
CA PJ15 cells was increased, while both HT25 and HT29 
Figure 3: Effect of hypoxia on protein expression and in vivo metastasis of human tumor xenografts. (A-B) Protein 
expression of small GTPases and HIF-1α in HT168-M1 and HT29 cells under hypoxic conditions (1% O
2
 level) compared to normoxia 
(a representative blot). (C) HT168-M1 human melanoma cells were injected intrasplenically and liver colonies formed were counted at day 
34 of the treatment. (D) HT29 human colon cancer fragments were orthotopically transplanted to the appendix region and liver and lung 
metastases were counted at day 34. Note that the CoCl
2
 treatment increased metastasis formation by the highly motile HT168-M1 cells. 
Inhibition of HIF proteins by chetomin, on the other hand, resulted in a significant decrease in the metastatic potential. However, CoCl
2
 or 
chetomin treatment had no effect on the metastatic capacity of HT29 cells. Data represent mean ± SEM of two independent experiments; 
*p<0.05.
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colon carcinoma cell lines were immotile in the modified 
Boyden chamber.
In the case of Boyden chamber assay, 
reoxygenization may have a role in the migration process, 
while the migratory capacity of HT168-M1 cells in 6 hour 
hypoxia without hypoxic preincubation period showed 
similar result as with 72 h hypoxic preincubation. In a 
previous study, hypoxic exposure increased the metastatic 
ability of HT1080 fibrosarcoma cells in a similar 
experimental setting. Reoxygenation for 6 to 18 h showed 
a trend for further increase, but it was not significant, 
while after 24 h of reoxygenation, the metastatic efficiency 
started to decline and following 48 h of reoxygenation, it 
was similar to that of the normoxic control groups [33].
To study the molecular response to hypoxia, 
we measured HIF-1α, RhoA, Rac1 and cdc42 mRNA 
levels and the activation of RhoA after preincubation 
for 72 hours under hypoxic conditions. We again found 
that hypoxia induced changes in mRNA level in a cell-
type dependent manner. In HT168-M1 cell line with high 
motility all four markers demonstrated higher mRNA 
level under both hypoxic conditions. However, mRNA 
expression levels in HT1080 cells were increased at 5%, 
but decreased at 1% oxygen concentration. These results 
Figure 4: Effect of HIF-1α gene silencing on protein and mRNA expression and RhoA activation. (A) HIF-1α protein 
expression in HIF-1α-silenced HT168-M1 cell lines. N: normoxic, H: hypoxic (1% O
2
) conditions. (B-C) Relative mRNA expression 
under hypoxic conditions compared to normoxic scramble-transfected human tumor cells (normoxic values=1, representative figures). (D-
E) RhoA activation in control, scramble-treated and HIF-1α silenced tumor cells under hypoxic (1% O
2
) conditions. Data are mean ± SD, 
n=3, *p<0.05.
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correlate with the proliferation data, but not with the 
migration analyses. Nevertheless, all four mRNA levels 
were decreased in the HT29 cell line under both hypoxic 
conditions. Moreover, we found decreased expression of 
HIF-1α in several other cell lines. It has been described 
that in prolonged hypoxia (12 h, 0.5% O
2
) the stability of 
HIF-1α mRNA is decreased, and the amount of natural 
antisense HIF-1α is increased, resulting in decreased HIF-
1α mRNA level [34]. During the 72 h incubation period 
applied in our experiment hypoxia may induce similar 
effect in certain cell lines.
Gilkes et al previously defined 3 HIF binding sites 
in RhoA and ROCK1 genes [17]. Our result showed 
that in HT168-M1 cells in which HIF-1α expression 
was increased at both oxygen levels, RhoA activation 
was elevated as well, while in HT29 cells the decreased 
HIF-1α expression correlated with the reduction of RhoA 
activation. However, in most of the cell lines, RhoA 
activation was independent of HIF-1α mRNA levels.
For further analyses, we chose the increased 
migratory and hypoxia responsive HT168-M1 and the less 
motile and rather hypoxia irresponsive HT29 cell lines. 
We investigated the protein expression level of HIF-1α 
and the three small GTPases after hypoxic incubation at 
1% O
2
 tension. HIF-1α protein expression was increased 
in both cell lines under hypoxia. Corresponding with the 
mRNA levels, protein expression was decreased in HT29 
cells, but RhoA and Rac1 expression increased compared 
to the normoxic amount in HT168-M1 cells.
The in vivo metastasis assays showed that CoCl
2
, 
applied for induction of HIF-1α stabilization, significantly 
increased the liver colonization capacity of HT168-M1 
cells, while the inhibition of HIF proteins decreased the 
number of tumor foci in the liver. However, there were 
no changes in the metastatic potential of HT29 xenografts 
after either induction of hypoxia or inhibition of HIF-1α.
In order to demonstrate the role of HIF-1α in the 
regulation of cell migration and metastatic potential, we 
downregulated HIF-1α by shRNA in the HT168-M1 and 
HT29 cell lines. In the highly motile HT168-M1 melanoma 
cells, where hypoxia increased the mRNA and protein 
expression of the three small G-proteins and increased the 
RhoA activation, HIF-1α silencing reverted these changes. 
Moreover, while the migration capacity of HIF-1α silenced 
HT168-M1 cells was unchanged under normoxia, the 
hypoxia-induced increased motility was blocked by HIF-
1α silencing. This result is in line with previous findings 
where in glioma cell lines downregulation of HIF-1α 
Figure 5: Effect of HIF-1α gene silencing on the migration and in vivo metastatic potential. (A-B), Baseline motility 
of HT168-M1 and HT29 tumor cell lines measured under normoxic (24 h) and hypoxic (1% O
2
) conditions for 72 h using time-lapse 
videomicroscopy. Curves represent the mean ± SD of migrated distance during the test period. (C), HIF-1α silenced HT168-M1 cells were 
injected intrasplenically and liver colonies formed were counted at day 34 of the treatment. Hypoxia means CoCl
2
 treatment. Data represent 
mean ± SEM, *p<0.05.
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expression inhibited migration and invasion capacity of 
the cells under hypoxic conditions [35]. However, in our 
experimental setup migration was increased under hypoxic 
conditions in the well-motile melanoma cell line, and 
HIF-1α silencing blocked this effect. We found similar 
effect in the in vivo metastasis experiment as well. The 
liver colonization capacity of melanoma cells, increased 
by CoCl
2
 administration, was decreased in the case of 
HIF-1α silenced cells. In a previous study, in vivo SW480 
cells were injected subcutaneously into nude mice and 
HIF siRNA was intraperitoneally administered; the tumor 
volume of the siHIF-1α group was much smaller than that 
of the negative control and saline-treated groups [36]. While 
this aforementioned study demonstrated the effect of HIF-
silencing on primary tumor growth, our study showed the 
involvement of HIF-1α in the metastatic process.
The majority of previous studies suggest that hypoxic 
conditions increase tumor cell aggressiveness through the 
activation of small GTPases [37, 38]. Similar to these 
findings we hereby demonstrated that the highly motile 
HT168-M1 melanoma cell line became more aggressive 
under hypoxia as manifested by increased migration and in 
vivo metastasis formation. Hypoxia induced the expression 
of HIF-1α, RhoA, Rac1, and cdc42 at mRNA as well 
as protein level, and enhanced the activation of RhoA. 
Nevertheless, opposite effects of hypoxia were observed 
in the case of the less motile HT29 colon cancer cell line. 
Altogether our study demonstrates that hypoxia-induced 
changes in cell migration and metastatic potential are cell-
type dependent and are at least in part mediated by HIF-1α.
METHODS
Cell lines and tissue culture conditions
HT168-M1 melanoma, HT1080 (ATCCCCL-121) 
human fibrosarcoma, HT25 (MJ Hendrix, University 
of Iowa, IA), HT29 (ATCCHTB-38) human colon 
adenocarcinomas and PE/CA PJ15 (ECACC 96121230) 
head and neck carcinoma cell lines were tested by STR 
analysis (AmpFISTR Identifiler Kit, fragment analysis 
by capillary electrophoresis) within 6 months. The highly 
metastatic HT168-M1 human melanoma cell line, derived 
from the A2058 cell line (ATCCCRL-11147), were 
selected in a liver colonization model [39]. PE/CA PJ15 
cells were cultured in Iscove’s MEM (Sigma-Aldrich, 
St. Louis, MO, USA) while the others in RPMI-1640 
Medium (Sigma-Aldrich), supplemented with 5-10% fetal 
bovine serum (Sigma-Aldrich) and antibiotics (Penicillin/
streptomycin, 1:100, Sigma-Aldrich) in humidified 
environment with atmospheric air containing 5% CO
2
.
Hypoxic cultures
To establish hypoxic conditions, cells were placed in 
a hypoxic chamber (Billups-Rothenberg, San Diego, CA, 
USA) flushed with a gas mixture of 5% CO
2
, 90% or 94% 
N
2
 and 1% or 5% O
2
, respectively. The hypoxic chamber 
was then placed in a 37˚C incubator for 72 hours.
Cells from hypoxic cultures were investigated 
immediately after incubation (mRNA for PCR and protein 
extraction for Western blot analysis, activation assay, cell 
count), or used in Boyden chamber migration assay under 
normoxia.
CoCl
2
, as a chemical-induced hypoxia agent was 
used in vitro to produce the same effect as hypoxic 
chamber. HT168-M1 and HT29 cells were treated with 
200 μM CoCl
2
 under normoxic conditions for 6 and 24 h 
to confirm the results obtained using the hypoxia chamber.
HIF-1α silencing
We used a plasmid encoding short hairpin RNA 
(shRNA) (Gene ID 3091) with MegaTran1.0 transfection 
reagent (OriGene, Rockville, MD, USA) to silence 
HIF-1α expression in HT168-M1 and HT29 cell lines. 
The transfection procedure was performed according to 
the manufacturer’s instructions. After the transfection, 
puromycin was added as selection marker.
Proliferation assays
The effect of hypoxia on cell proliferation capacity 
was determined by proliferation assays. Briefly, 1-5×103 
tumor cells in six parallels were plated onto a 96-well plate 
and allowed to adhere. The next day, plates were placed 
into the hypoxic chamber. After a 72-hour incubation 
period cell density was evaluated by sulforhodamine 
B (SRB) assay (Sigma-Aldrich). Cell were fixed with 10% 
trichloroacetic acid for 60 minutes and stained with 0.4% 
sulforhodamine B for 15 minutes, after which the excess 
dye was removed by washing repeatedly with 1% acetic 
acid. The protein-bound dye was dissolved in 10 mM 
Tris base solution for OD determination at 570 nm using 
Bio-Rad 550 Microplate Reader (Bio-Rad Laboratories, 
Berkeley, CA, USA). Results were compared to those 
obtained with control cells (cultured in normoxia for 
72 hours) and expressed as average percentages relative 
to values obtained in control (normoxic) cultures.
Real-time reverse transcription PCR
Total RNA was isolated using TRIzol Reagent 
(Invitrogen, Life Technologies, Carlsbad, CA, USA) 
according to the manufacturer’s protocol. The purity 
and concentration of RNA were determined using a 
spectrophotometer at 260 nm (NanoDrop, Wilmington, 
DE, USA). RNA was reverse transcribed using the High-
Capacity cDNA Reverse Transcription Kit (Invitrogen, 
Life Technologies) according to the manufacturer`s 
instructions. After reverse transcription, cDNA samples 
were stored at −70°C until further processing. Quantitative 
real-time PCR reactions were performed using the iCycler 
iQ detection systems (Bio-Rad). The quantitative PCR 
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was performed according to the manufacturer’s instruction 
(primers ID: human HIF-1α (Hs00936366_m1), RhoA 
(Hs00236938_m1), Rac1 (Hs01902432_s1), cdc42 
(Hs00741586_mH), β-actin (FAM/MGB 4333762). 
mRNA expression was determined with relative 
quantification using threshold cycle (CT) values and 
analyzed by the 2−ΔΔCt. method.
Modified Boyden chamber migration assay
The cell migration assay was performed in a 
modified 48-well Boyden chamber using polycarbonate 
nucleopore membrane with 8-µm pore size (Whatman, 
Piscataway, NJ, USA). Briefly, subconfluent tumor cells 
were trypsinized, and 20,000 cells/well were plated onto 
the upper chamber of each well. Fibronectin (Sigma-
Aldrich) at a concentration of 100 µg/ml was added into 
the serum-free medium in the lower chambers. Cells were 
allowed to migrate for 6 hours (HT168-M1, HT1080) or 
20 hours (HT25, HT29, PE/CA PJ15). Then, the upper 
surface of the membrane was wiped with PBS to remove 
any non-migrated cells. Cells that had migrated to the 
lower surface of the membrane were fixed with methanol, 
stained with Toluidine-blue solution (Sigma-Aldrich), and 
counted under a microscope. To measure the migration 
activity of cells within individual wells, the mean number 
of cells from five randomly chosen fields was determined 
at 20x magnification with an eyepiece equipped with a 
square grid. The results for each culture condition were 
expressed as the mean ± SD of six individual wells.
To avoid the effect of reoxygenation on migration 
capacity, HT168-M1 cells were migrated in hypoxia 
without 72-hour hypoxic preincubation as well.
Time-lapse videomicroscopy
Videomicroscopy measurements were performed 
and analyzed as described previously [40, 41]. Briefly, 
the cells were plated in the inner 8 wells of 24-well plates 
(Sarstedt, Nümbrecht, Germany) in RPMI-1640 medium 
supplemented with 10% fetal bovine serum (Sigma-
Aldrich). The medium was changed to CO
2
-independent 
medium (Gibco-BRL, Life Technologies, Rockville, MD, 
USA) supplemented with 10% fetal bovine serum and 
4 mM glutamine after the overnight cell attachment. In 
order to reduce evaporation from the inner wells, the outer 
wells were filled with medium. Cells were kept in a custom-
designed incubator built around an inverted phase-contrast 
microscope (World Precision Instruments, Sarasota, FL, 
USA) at 37°C and room ambient atmosphere. Images of 
3 not overlapping microscopic view areas were taken 
every 5 minutes for 1 day before and 3 days after changing 
the oxygen tension (normoxic to hypoxic mixtures). For 
migration data the captured phase contrast microscope 
pictures were analyzed individually using a custom-
made cell-tracking software enabling manual marking of 
individual cells. The parameter of migrated distance was 
calculated by averaging the displacement of the cells for 
each 24-hour interval for 4 consecutive days in the case 
of each cell line, in two independent experiments and 
3 microscopic fields. The results were expressed in relative 
migration of the cells detected during the 72-96 h period 
(third day in hypoxia) relative to that observed during the 
first 24 hours (normoxia).
Determination of active RhoA
Active, GTP-bound form of RhoA was determined 
using the G-LISA kit (Cytoskeleton, Denver, Co, USA) 
according to the manufacturer`s instructions.
Western blot analysis
After incubation for 72 hours, cultured cells were 
washed two times by Tris-buffered saline, then lysed with 
MLB (Millipore, Billerica, MA, USA) cell lysis solution 
containing 10 µg/ml aprotinin and 10 µg/ml leupeptin, and 
removed from the flask surface using a cell scraper. The 
samples were then homogenized by pressing the lysates 
through 26 and 28-gauge needles (5 times) and centrifuged 
for 2 minutes at 14,000xg, and the supernatant was used 
for the analysis. The samples were diluted 1:1 by 2x 
Laemmli buffer (Sigma-Aldrich), and stored at −80°C 
until further use. The whole procedure was performed on 
ice to avoid protein degradation. Proteins were separated 
in a 10% SDS-polyacrylamide gel, then transferred to a 
PVDF membrane (Bio-Rad), using a wet electroblotting 
apparatus according to the manufacturer’s protocols. 
Rho was detected using anti-Rho (-A, -B, -C) clone 55 
(#17-294, Millipore) diluted to 3 μg/ml concentration. 
Rac1 and cdc42 were detected using anti-Rac1 (clone 
23A8) and anti-cdc42 mouse monoclonal antibody (#17-
441, Millipore) diluted to 1 μg/ml concentration. HIF-
1α was detected using anti-HIF-1α rabbit monoclonal 
antibody (OriGene), diluted 2 μg/ml concentration. All of 
them were detected by HRP-conjugated goat anti-mouse 
IgG secondary antibody (Jackson ImmunoResearch, 
West Grove, PA, USA). Immunoblots were revealed by 
enhanced chemiluminescence system (Millipore). The 
bands were evaluated and quantified using GelAnalyzer 
2010a software (Lazar Software, Debrecen, Hungary) 
and protein expressions were normalized to the level of 
beta-actin.
Animal experiments
All animal-model protocols were carried out in 
accordance with the Guidelines for Animal Experiments 
and were approved by the Institutional Ethics Committee 
at the National Institute of Oncology, Budapest, Hungary 
(permission number: 22.1/722/3/2010). Male SCID mice 
(CB17/Icr-Prkdcscid) from our colony were used for the 
experiments. To analyze the effect of hypoxic conditions 
on metastasis formation in vivo we used two types of 
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colonization and metastasis models. Single-cell suspensions 
were prepared from HT168-M1 monolayer cultures, 
washed and diluted in Medium 199 (Sigma-Aldrich). 
1×105 tumor cells were injected in a volume of 50 µl into 
the spleen of mice from where metastatic colonies formed 
in the liver. HT29 tumor fragments from subcutaneously 
growing lesions were transplanted orthotopically to the 
appendix region. From the latter site metastases are known 
to form in the liver and the lung as well. The treatments 
started on day 6 after tumor transplantation (10-11 mice/
group were used in the case of HT168-M1, and 8 mice/
group in the case of HT29). Animals on the treatment arm 
were randomized into three groups: control (6.25% DMSO 
in PBS intraperitoneally, twice a week for 4 weeks), CoCl
2
 
(best known chemical inducer of hypoxia, 260 mg/l in 
drinking water per os for 4 weeks) and chetomin (Sigma-
Aldrich, 1 mg/kg dissolved in DMSO intraperitoneally, 
twice a week for 4 weeks) groups. Chetomin is known as a 
selective inhibitor of HIF-1α, quenching hypoxia-inducible 
gene expression by inhibiting the formation of the HIF-1α/
p300 complex. Experiments were terminated on day 34 
after tumor inoculations. Liver and lungs with metastases 
were fixed in formalin and the metastases were counted 
under stereomicroscope.
For the investigation of HIF silencing in case of the 
melanoma cell line, single-cell suspensions were prepared from 
HT168-M1, scrambled- and shHIF-transfected monolayer 
cultures as well, washed and diluted in Medium 199 (Sigma). 
1×105 tumor cells were injected in a volume of 50 µl into the 
spleen of mice from where metastatic colonies formed in the 
liver. During the experiment, the hypoxic conditions were 
mimicked by CoCl
2
 treatment: 260 mg/l CoCl
2
 in the drinking 
water of the animals in the hypoxic arm.
Statistical analyses
To determine statistical differences between 
different strata ANOVA (analyses of variance) was used 
with the post hoc Scheffé-test, where parametric methods 
were available. For the animal experiments we used 
the non-parametric Kruskal-Wallis test with post hoc 
analysis. Statistical significance was determined when 
P values were <0.05. Statistical analysis was performed 
by Statistica 12.0 software (StatSoft, Tulsa, OK).
Abbreviations
ANOVA analysis of variance
cDNA complementary deoxyribonucleic acid
DMSO dimethyl sulfoxide
GAP GTPase-activating protein
GDI guanosine nucleotide dissociation inhibitor
GEF Guanine nucleotide exchange factors
HIF-1α Hypoxia-inducible factor 1-alpha
HIF-1β Hypoxia-inducible factor 1-beta
HRE Hypoxia-Response Element
HRP horseradish peroxidase
i.p. intraperitoneal
mRNA messenger ribonucleic acid
PBS Phosphate-buffered saline
PCR Polymerase chain reaction
PVDF Polyvinylidene fluoride
SCID Severe combined immunodeficiency
SD standard deviation
SEM standard error of mean
shRNA short hairpin ribonucleic acid
SRB sulforhodamine B
VEGF Vascular endothelial growth factor
Authors contributions
JT, SP designed the study, ET, AG, AB, ZH 
performed the proliferation, activation and migration 
assays, and measured mRNA levels with quantitative 
real time PCR, and created the knockdown cell lines, 
BH, TG, EM performed and analyzed video microscopy 
experiments, MC, NK and GS performed and evaluated 
western blot analyses, ET, JT, IK, AG performed in vivo 
experiments, IK carried out the statistical analyses of the 
results, JT, GS assisted preparing the manuscript, JT, MC, 
IK revised the manuscript.
ACKNOWLEDGMENTS
We kindly thank Katalin Derecskei and Ákos 
Schulcz for the excellent technical assistance and Andrea 
Ladányi for the critical review of the manuscript.
CONFLICTS OF INTEREST
The authors declare no competing interest.
FUNDING
This work was supported by grants from National 
Research, Development and Innovation Office – NKFIH 
K84173 and K116295 (JT), PD109580 (IK), MOB 80325 
(BH), National Development Agency-NFU KTIA AIK 
12-1-2013-0041 (JT) and INNO 08-3-2009-0248 (JT). GS 
was supported by a Momentum Grant of the Hungarian 
Academy of Sciences. IK is a recipient of János Bolyai 
Research Scholarships of the Hungarian Academy of 
Sciences.
REFERENCES
1. Harris AL. Hypoxia--a key regulatory factor in tumour growth. 
Nat Rev Cancer. 2002; 2: 38-47. doi: 10.1038/nrc704.
2. Vaupel P, Thews O, Hoeckel M. Treatment resistance of 
solid tumors: role of hypoxia and anemia. Med Oncol. 
2001; 18: 243-59. doi: 10.1385/mo:18:4:243.
Oncotarget44509www.impactjournals.com/oncotarget
3. Brown JM, Giaccia AJ. The unique physiology of solid 
tumors: opportunities (and problems) for cancer therapy. 
Cancer Res. 1998; 58: 1408-16.
4. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-
inducible factor 1 is a basic-helix-loop-helix-PAS 
heterodimer regulated by cellular O2 tension. Proc Natl 
Acad Sci U S A. 1995; 92: 5510-4.
5. Dai Y, Bae K, Siemann DW. Impact of hypoxia on the metastatic 
potential of human prostate cancer cells. Int J Radiat Oncol Biol 
Phys. 2011; 81: 521-8. doi: 10.1016/j.ijrobp.2011.04.027.
6. Loboda A, Jozkowicz A, Dulak J. HIF-1 and HIF-2 
transcription factors--similar but not identical. Mol Cells. 
2010; 29: 435-42. doi: 10.1007/s10059-010-0067-2.
7. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev 
Cancer. 2003; 3: 721-32. doi: 10.1038/nrc1187.
8. Semenza GL. HIF-1 mediates metabolic responses to 
intratumoral hypoxia and oncogenic mutations. J Clin 
Invest. 2013; 123: 3664-71. doi: 10.1172/jci67230.
9. Semenza GL. Hypoxia, clonal selection, and the role of 
HIF-1 in tumor progression. Crit Rev Biochem Mol Biol. 
2000; 35: 71-103. doi: 10.1080/10409230091169186.
10. Xue Y, Bi F, Zhang X, Zhang S, Pan Y, Liu N, Shi Y, Yao 
X, Zheng Y, Fan D. Role of Rac1 and Cdc42 in hypoxia 
induced p53 and von Hippel-Lindau suppression and 
HIF1alpha activation. Int J Cancer. 2006; 118: 2965-72. 
doi: 10.1002/ijc.21763.
11. Jaffe AB, Hall A. Rho GTPases: biochemistry and biology. 
Annu Rev Cell Dev Biol. 2005; 21: 247-69. doi: 10.1146/
annurev.cellbio.21.020604.150721.
12. Roux P, Gauthier-Rouviere C, Doucet-Brutin S, Fort P. The 
small GTPases Cdc42Hs, Rac1 and RhoG delineate Raf-
independent pathways that cooperate to transform NIH3T3 
cells. Curr Biol. 1997; 7: 629-37. 
13. Ridley AJ. Rho GTPases and cell migration. J Cell Sci. 
2001; 114: 2713-22. 
14. Sherr CJ, Roberts JM. CDK inhibitors: positive and 
negative regulators of G1-phase progression. Genes Dev. 
1999; 13: 1501-12. 
15. Coleman ML, Olson MF. Rho GTPase signalling pathways 
in the morphological changes associated with apoptosis. 
Cell Death Differ. 2002; 9: 493-504. doi: 10.1038/sj/
cdd/4400987.
16. Raheja LF, Genetos DC, Wong A, Yellowley CE. Hypoxic 
regulation of mesenchymal stem cell migration: the role of 
RhoA and HIF-1alpha. Cell Biol Int. 2011; 35: 981-9. doi: 
10.1042/cbi20100733.
17. Gilkes DM, Xiang L, Lee SJ, Chaturvedi P, Hubbi ME, 
Wirtz D, Semenza GL. Hypoxia-inducible factors mediate 
coordinated RhoA-ROCK1 expression and signaling in 
breast cancer cells. Proc Natl Acad Sci U S A. 2014; 111: 
E384-93. doi: 10.1073/pnas.1321510111.
18. Zhou J, Dehne N, Brune B. Nitric oxide causes macrophage 
migration via the HIF-1-stimulated small GTPases Cdc42 
and Rac1. Free Radic Biol Med. 2009; 47: 741-9. doi: 
10.1016/j.freeradbiomed.2009.06.006.
19. Vogel S, Wottawa M, Farhat K, Zieseniss A, Schnelle M, 
Le-Huu S, von Ahlen M, Malz C, Camenisch G, Katschinski 
DM. Prolyl hydroxylase domain (PHD) 2 affects cell 
migration and F-actin formation via RhoA/rho-associated 
kinase-dependent cofilin phosphorylation. J Biol Chem. 
2010; 285: 33756-63. doi: 10.1074/jbc.M110.132985.
20. Singleton DC, Rouhi P, Zois CE, Haider S, Li JL, Kessler 
BM, Cao Y, Harris AL. Hypoxic regulation of RIOK3 is a 
major mechanism for cancer cell invasion and metastasis. 
Oncogene. 2015; 34: 4713-22. doi: 10.1038/onc.2014.396.
21. Rohwer N, Cramer T. Hypoxia-mediated drug resistance: 
novel insights on the functional interaction of HIFs and cell 
death pathways. Drug Resist Updat. 2011; 14: 191-201. doi: 
10.1016/j.drup.2011.03.001.
22. Moeller BJ, Richardson RA, Dewhirst MW. Hypoxia and 
radiotherapy: opportunities for improved outcomes in 
cancer treatment. Cancer Metastasis Rev. 2007; 26: 241-8. 
doi: 10.1007/s10555-007-9056-0.
23. Hongo K, Tsuno NH, Kawai K, Sasaki K, Kaneko M, 
Hiyoshi M, Murono K, Tada N, Nirei T, Sunami E, 
Takahashi K, Nagawa H, Kitayama J, et al. Hypoxia 
enhances colon cancer migration and invasion through 
promotion of epithelial-mesenchymal transition. J Surg Res. 
2013; 182: 75-84. doi: 10.1016/j.jss.2012.08.034.
24. Yu L, Hales CA. Long-term exposure to hypoxia inhibits 
tumor progression of lung cancer in rats and mice. BMC 
Cancer. 2011; 11: 331. doi: 10.1186/1471-2407-11-331.
25. Murono K, Tsuno NH, Kawai K, Sasaki K, Hongo K, Kaneko 
M, Hiyoshi M, Tada N, Nirei T, Sunami E, Takahashi K, 
Kitayama J. SN-38 overcomes chemoresistance of colorectal 
cancer cells induced by hypoxia, through HIF1alpha. 
Anticancer Res. 2012; 32: 865-72.  
26. Wang X, Schneider A. HIF-2alpha-mediated activation 
of the epidermal growth factor receptor potentiates head 
and neck cancer cell migration in response to hypoxia. 
Carcinogenesis. 2010; 31: 1202-10. doi: 10.1093/carcin/
bgq078.
27. Noda S, Yashiro M, Nshii T, Hirakawa K. Hypoxia 
upregulates adhesion ability to peritoneum through a 
transforming growth factor-beta-dependent mechanism in 
diffuse-type gastric cancer cells. Eur J Cancer. 2010; 46: 
995-1005. doi: 10.1016/j.ejca.2010.01.007.
28. Zhao XY, Chen TT, Xia L, Guo M, Xu Y, Yue F, Jiang Y, 
Chen GQ, Zhao KW. Hypoxia inducible factor-1 mediates 
expression of galectin-1: the potential role in migration/
invasion of colorectal cancer cells. Carcinogenesis. 2010; 
31: 1367-75. doi: 10.1093/carcin/bgq116.
29. Ryu MH, Park HM, Chung J, Lee CH, Park HR. Hypoxia-
inducible factor-1alpha mediates oral squamous cell 
carcinoma invasion via upregulation of alpha5 integrin and 
fibronectin. Biochem Biophys Res Commun. 2010; 393: 
11-5. doi: 10.1016/j.bbrc.2010.01.060.
Oncotarget44510www.impactjournals.com/oncotarget
30. Rofstad EK, Galappathi K, Mathiesen B, Ruud EB. 
Fluctuating and diffusion-limited hypoxia in hypoxia-
induced metastasis. Clin Cancer Res. 2007; 13: 1971-8. doi: 
10.1158/1078-0432.ccr-06-1967.
31. Cairns RA, Kalliomaki T, Hill RP. Acute (cyclic) hypoxia 
enhances spontaneous metastasis of KHT murine tumors. 
Cancer Res. 2001; 61: 8903-8. 
32. Cairns RA, Hill RP. Acute hypoxia enhances spontaneous 
lymph node metastasis in an orthotopic murine model 
of human cervical carcinoma. Cancer Res. 2004; 64: 
2054-61. 
33. Zhang L, Hill RP. Hypoxia enhances metastatic efficiency 
in HT1080 fibrosarcoma cells by increasing cell survival in 
lungs, not cell adhesion and invasion. Cancer Res. 2007; 67: 
7789-97. doi: 10.1158/0008-5472.can-06-4221.
34. Uchida T, Rossignol F, Matthay MA, Mounier R, Couette 
S, Clottes E, Clerici C. Prolonged hypoxia differentially 
regulates hypoxia-inducible factor (HIF)-1alpha and HIF-
2alpha expression in lung epithelial cells: implication of 
natural antisense HIF-1alpha. J Biol Chem. 2004; 279: 
14871-8. doi: 10.1074/jbc.M400461200.
35. Fujiwara S, Nakagawa K, Harada H, Nagato S, Furukawa 
K, Teraoka M, Seno T, Oka K, Iwata S, Ohnishi T. Silencing 
hypoxia-inducible factor-1alpha inhibits cell migration and 
invasion under hypoxic environment in malignant gliomas. 
Int J Oncol. 2007; 30: 793-802. 
36. Wu XY, Fu ZX, Wang XH. Effect of hypoxia-inducible 
factor 1-alpha on Survivin in colorectal cancer. Mol Med 
Rep. 2010; 3: 409-15. doi: 10.3892/mmr_00000273.
37. Thews O, Wolloscheck T, Dillenburg W, Kraus S, Kelleher 
DK, Konerding MA, Vaupel P. Microenvironmental adaptation 
of experimental tumours to chronic vs acute hypoxia. Br J 
Cancer. 2004; 91: 1181-9. doi: 10.1038/sj.bjc.6602066.
38. Alqawi O, Wang HP, Espiritu M, Singh G. Chronic 
hypoxia promotes an aggressive phenotype in rat prostate 
cancer cells. Free Radic Res. 2007; 41: 788-97. doi: 
10.1080/10715760701361531.
39. Ladanyi A, Timar J, Paku S, Molnar G, Lapis K. Selection 
and characterization of human melanoma lines with different 
liver-colonizing capacity. Int J Cancer. 1990; 46: 456-61. 
40. Hegedus B, Czirok A, Fazekas I, B'Abel T, Madar'asz E, 
Vicsek T. Locomotion and proliferation of glioblastoma 
cells in vitro: statistical evaluation of videomicroscopic 
observations. J Neurosurg. 2000; 92: 428-34. doi: 10.3171/
jns.2000.92.3.0428.
41. Garay T, Juhasz E, Molnar E, Eisenbauer M, Czirok A, 
Dekan B, Laszlo V, Hoda MA, Dome B, Timar J, Klepetko 
W, Berger W, Hegedus B. Cell migration or cytokinesis and 
proliferation?--revisiting the "go or grow" hypothesis in 
cancer cells in vitro. Exp Cell Res. 2013; 319: 3094-103. 
doi: 10.1016/j.yexcr.2013.08.018.
